METASTATIC TUMOR
Clinical trials for METASTATIC TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to revive immunotherapy in resistant cancers
Disease control Recruiting nowThis early-stage trial tests whether adding a chemotherapy drug (5-Azacitidine) to standard immunotherapy can help patients whose solid tumors have stopped responding to PD-1/PD-L1 inhibitors. About 35 adults with advanced or metastatic cancers will receive the combination to fin…
Matched conditions: METASTATIC TUMOR
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called NKT3964 in adults with advanced or metastatic solid tumors that have not responded to standard treatments. The drug works by degrading a protein (CDK2) that helps cancer cells grow. The study has two parts: first, find…
Matched conditions: METASTATIC TUMOR
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New trial: can targeted radiation boost survival in patients with up to 10 metastases?
Disease control Recruiting nowThis phase III trial tests whether adding stereotactic ablative radiotherapy (SABR) to standard treatment (chemotherapy, hormone therapy, or palliative radiation) improves survival in adults with 1 to 10 metastatic tumors and an active primary cancer. About 180 participants will …
Matched conditions: METASTATIC TUMOR
Phase: PHASE3 • Sponsor: David Palma • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC